BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23374503)

  • 1. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
    Pang Q; Wei Q; Xu T; Yuan X; Lopez Guerra JL; Levy LB; Liu Z; Gomez DR; Zhuang Y; Wang LE; Mohan R; Komaki R; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1332-9. PubMed ID: 23374503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy.
    Lopez Guerra JL; Wei Q; Yuan X; Gomez D; Liu Z; Zhuang Y; Yin M; Li M; Wang LE; Cox JD; Liao Z
    Radiother Oncol; 2011 Nov; 101(2):271-7. PubMed ID: 21937138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.
    Xu T; Wei Q; Lopez Guerra JL; Wang LE; Liu Z; Gomez D; O'Reilly M; Lin SH; Zhuang Y; Levy LB; Mohan R; Zhou H; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e229-35. PubMed ID: 22608953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of LIG4 and HSPB1 genetic polymorphisms with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.
    Xu F; Han JC; Zhang YJ; Zhang YJ; Liu XC; Qi GB; Liu D; Chen YZ; Zhao YX; Bai L
    Biomed Res Int; 2015; 2015():860373. PubMed ID: 25811031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation.
    Enguix-Riego MDV; Cacicedo J; Delgado León BD; Nieto-Guerrero Gómez JM; Herrero Rivera D; Perez M; Praena-Fernández JM; Sanchez Carmona G; Rivin Del Campo E; Ortiz Gordillo MJ; Lopez Guerra JL
    Radiother Oncol; 2019 Jul; 136():29-36. PubMed ID: 31015126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM polymorphisms are associated with risk of radiation-induced pneumonitis.
    Zhang L; Yang M; Bi N; Fang M; Sun T; Ji W; Tan W; Zhao L; Yu D; Lin D; Wang L
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1360-8. PubMed ID: 20171797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
    Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.
    Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S
    J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy.
    Yang M; Zhang L; Bi N; Ji W; Tan W; Zhao L; Yu D; Wu C; Wang L; Lin D
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1402-7. PubMed ID: 20729006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.
    Guo H; Bai Y; Xu P; Hu Z; Liu L; Wang F; Jin G; Wang F; Deng Q; Tu Y; Feng M; Lu D; Shen H; Wu T
    J Clin Oncol; 2010 Apr; 28(11):1928-35. PubMed ID: 20231684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Yin M; Liao Z; Liu Z; Wang LE; Gomez D; Komaki R; Wei Q
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e67-73. PubMed ID: 21420246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Xiong H; Liao Z; Liu Z; Xu T; Wang Q; Liu H; Komaki R; Gomez D; Wang LE; Wei Q
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1066-73. PubMed ID: 23154078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSPB1 polymorphisms might be associated with radiation-induced damage risk in lung cancer patients treated with radiotherapy.
    Li X; Xu S; Cheng Y; Shu J
    Tumour Biol; 2016 May; 37(5):5743-9. PubMed ID: 26874728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.
    Wen J; Liu H; Wang L; Wang X; Gu N; Liu Z; Xu T; Gomez DR; Komaki R; Liao Z; Wei Q
    J Thorac Oncol; 2018 May; 13(5):660-675. PubMed ID: 29454863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Wen J; Liu H; Wang Q; Liu Z; Li Y; Xiong H; Xu T; Li P; Wang LE; Gomez DR; Mohan R; Komaki R; Liao Z; Wei Q
    Eur J Cancer; 2014 Jul; 50(10):1706-1716. PubMed ID: 24780874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.
    Tucker SL; Jin H; Wei X; Wang S; Martel MK; Komaki R; Liu HH; Mohan R; Chen Y; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):691-8. PubMed ID: 19836159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.